Zhou‐Tong Dai

511 citations
26 papers · 372 indexed · h-index 12
Topics
Cancer-related molecular mechanisms research (9 papers)RNA modifications and cancer (7 papers)MicroRNA in disease regulation (6 papers)
Journals
SHILAP Revista de lepidopterologíaScientific ReportsInternational Journal of Molecular Sciences

In The Last Decade

Zhou‐Tong Dai

26 papers receiving 372 citations

Peers

Zhou‐Tong Dai
Comparison fields: 5 of 71
  • Molecular Biology 238
  • Cancer Research 151
  • Oncology 51
  • Pulmonary and Respiratory Medicine 46
  • Epidemiology 44
Replace Miaomiao Ge with:
Miaomiao Ge China
Shaowen Jiang United States
Silvia Cecilia Pacheco-Velázquez Mexico
Liangning Hu China
Kulsoom Zahra India
Tanushree Ghosh India
Bingqian Xie China
Jiantao Jiang China
Zhou‐Tong Dai relative to Miaomiao Ge China Miaomiao Ge's profile →
Citations per field
00.5×
Miaomiao Ge · 1×
Citations per year

Countries citing papers authored by Zhou‐Tong Dai

Since Specialization
Citations

This map shows the geographic impact of Zhou‐Tong Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhou‐Tong Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhou‐Tong Dai more than expected).

Fields of papers citing papers by Zhou‐Tong Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhou‐Tong Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhou‐Tong Dai. The network helps show where Zhou‐Tong Dai may publish in the future.

Co-authorship network of co-authors of Zhou‐Tong Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhou‐Tong Dai. A scholar is included among the top collaborators of Zhou‐Tong Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhou‐Tong Dai. Zhou‐Tong Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 3
3 9
4 3
5 7
6 8
7 13
8 17
9 22
10 9
11 17
12 16
13 9
14 8
15 5
16 45
17 21
18 46
19 31
20 4

About Zhou‐Tong Dai

Zhou‐Tong Dai is a scholar working on Cancer Research, Molecular Biology and Biochemistry, having authored 26 papers that have together received 372 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (151 citations), Molecular Biology (238 citations) and Toxicology (8 citations). Zhou‐Tong Dai has collaborated with scholars based in China, United Kingdom and Russia. Frequent co-authors include Xing‐Hua Liao, Xiang Yuan, Jia‐Peng Li, Huimin Zhang, Tongcun Zhang, Feng Huang, Hui Li, Tongcun Zhang, Chao Shen and Hanhan Li. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026